Kerstin Westman
41 – 50 of 83
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
A Model to Predict Cardiovascular Events in Patients With Newly Diagnosed Wegener's Granulomatosis and Microscopic Polyangiitis
- Contribution to journal › Article
-
Mark
Long-term patient survival in ANCA-associated vasculitis
- Contribution to journal › Article
-
Mark
Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index
- Contribution to journal › Article
-
Mark
Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials.
- Contribution to journal › Article
-
Mark
A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis.
- Contribution to journal › Article
- 2010
-
Mark
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis.
- Contribution to journal › Article
-
Mark
A Model To Predict Cardiovascular Events In Patients With Newly Diagnosed Wegener'S Granulmoatosis And Microscopic Polyangiitis
(2010) Annual Meeting of the British-Society-Rheumatology/Spring Meeting of British-Health-Professional-in-Rheumatology In Rheumatology 49. p.124-124
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS
- Contribution to journal › Published meeting abstract
-
Mark
Pulse vs daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: a randomized controlled trial
- Contribution to journal › Published meeting abstract
-
Mark
EULAR recommendations for the management of large vessel vasculitis
- Contribution to journal › Article
